Delivery Order SPE2DB22D1106-SPE2DB23FEVC6
Award Date 8/14/23
Potential Completion Date 8/15/23
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency awarded a $14,358 delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Remicade. The firm fixed price order is for performance at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 18-19, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order supports DOD medical supply needs.</p>
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $17,733.06 from the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Remicade 100 mg vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a $15,907 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 mg vials of the drug Remicade. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 21, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $3,032.89 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract, awarded September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- The Defense Logistics Agency awarded a $50,458.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 21, 2025. This is a non-set-aside competitive award issued on August 20, 2025, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $36,525 firm fixed price delivery order for 100 mg vials of Remicade. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 1, 2023 under the terms of the order. The Defense Logistics Agency supports Department of Defense procurement through contracts such as this for supplies including medical products. No set aside designation or...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $14,129.28 to Amerisourcebergen Drug Corporation for 100mg vials of the biologic drug Remicade. Performance will take place in Conshohocken, Pennsylvania over a two day period from September 7-8, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor to supply this order for Remicade through its corporate office division...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $4,415 firm fixed price delivery order contract to provide 100 mg vials of Remicade. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 29, 2023 under the terms of the order. The Defense Logistics Agency utilizes contracts such as this to efficiently acquire necessary medical supplies in support of Department of Defense programs and...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.28 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $18,837.70 delivery order on August 19, 2025, for the supply of Remicade 100 mg vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEVC6Delivery Order
The Defense Logistics Agency awarded a $3,532 delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Remicade. The firm fixed price order is for performance at Amerisourcebergen's facility in Conshohocken, Pennsylvania from August 14 to August 15, 2023. As a major pharmaceutical distributor, Amerisourcebergen supports the DLA's medical supply chain requirements through its Prime Vendor Next contract vehicle. No subcontractors or set aside designations were identified for this order to supply the monoclonal antibody treatment for approved clinical indications including rheumatoid arthritis and inflammatory bowel disease.
Generated 12/20/23, 3:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/14/23 |